Stansberry Asset Management, LLC Caribou Biosciences, Inc. Transaction History

Stansberry Asset Management, LLC

  • $721 Million
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$1.62 - $5.05 $55,676 - $173,558
-34,368 Reduced 53.42%
29,969 $49,000
Q1 2024

May 14, 2024
SELL
$4.82 - $8.26 $62,153 - $106,512
-12,895 Reduced 16.7%
64,337 $330,000
Q3 2023

Nov 14, 2023
BUY
$4.08 - $8.14 $23,406 - $46,699
5,737 Added 8.02%
77,232 $369,000
Q2 2023

Aug 17, 2023
SELL
$4.04 - $5.47 $735,510 - $995,851
-182,057 Reduced 71.8%
71,495 $303,000
Q2 2023

Aug 11, 2023
BUY
$4.04 - $5.47 $738,087 - $999,341
182,695 Added 257.84%
253,552 $1.08 Million
Q1 2023

May 12, 2023
BUY
$4.3 - $7.78 $3,667 - $6,636
853 Added 1.22%
70,857 $376,000
Q4 2022

Feb 13, 2023
BUY
$5.57 - $11.01 $13,044 - $25,785
2,342 Added 3.46%
70,004 $439,000
Q3 2022

Nov 14, 2022
SELL
$5.34 - $12.79 $8,949 - $21,436
-1,676 Reduced 2.42%
67,662 $714,000
Q2 2022

Aug 15, 2022
SELL
$5.1 - $9.74 $119,600 - $228,412
-23,451 Reduced 25.27%
69,338 $376,000
Q1 2022

May 16, 2022
BUY
$8.42 - $15.32 $214,019 - $389,403
25,418 Added 37.73%
92,789 $852,000
Q4 2021

Feb 14, 2022
BUY
$14.59 - $23.26 $584,285 - $931,493
40,047 Added 146.56%
67,371 $1.02 Million
Q3 2021

Nov 15, 2021
BUY
$15.75 - $30.29 $430,353 - $827,643
27,324 New
27,324 $652,000

Others Institutions Holding CRBU

# of Institutions
136
Shares Held
52.6M
Call Options Held
148K
Put Options Held
70.7K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $91.9M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Stansberry Asset Management, LLC Portfolio

Follow Stansberry Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stansberry Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email